Relationship between abdominal adiposity, cardiovascular fitness, and biomarkers of cardiovascular risk in British adolescents.

BACKGROUND: Puberty is a critical time in the development of overweight and obesity. The aim of this study was to examine relationships between measures of adiposity, cardiovascular fitness, and biomarkers of cardiovascular disease risk in adolescents.
METHODS: In a cross-sectional study design, 129 girls and 95 boys aged 12.9-14.4 years at various stages of puberty were included, along with their mothers (n = 217) and fathers (n = 207). Anthropometric assessments of adiposity were made, along with cardiovascular physical fitness, using the 20-m shuttle run test, and biomarkers associated with cardiovascular risk, including glucose, insulin, triglyceride, fibrinogen, and C-reactive protein (CRP) concentrations.
RESULTS: Waist-to-height ratio values were similar in boys and girls and correlated positively with diastolic blood pressure, insulin, triglyceride, fibrinogen, and CRP concentrations, and inversely with cardiovascular fitness scores. Skinfold thickness measurements were higher in girls. High-molecular-weight adiponectin concentrations were lower in boys than girls, particularly in late puberty, and CRP levels were higher. Cardiovascular fitness, maternal body mass index (BMI), and paternal BMI contributed independently to the variance in waist measurements in girls and boys. Gender, triceps skinfold thickness, and weight-to-height ratio, but not parental BMI, contributed independently to the variance in cardiovascular fitness.
CONCLUSION: There is a relationship between measures of adolescent adiposity and parental weight that involves factors other than cardiovascular fitness. Adolescent boys have relatively more abdominal fat than girls and a tendency to have a proinflammatory profile of biomarkers. These observations suggest that family and social environmental interventions are best undertaken earlier in childhood, particularly among boys.

Introduction

Childhood obesity predicts obesity later in adulthood and is associated with adult cardiovascular disease and related mortality. The increasing prevalence of obesity in childhood is, therefore, likely to have pathophysiological consequences and translate to an increased incidence of cardiovascular events in adulthood. It is now recognized that there is an interaction between overweight and fitness that contributes to cardiovascular risk and prognosis. Adolescence is associated with increases in overweight and obesity and a decrease in levels of physical activity. Puberty is, therefore, a stage when the promotion of healthy behaviors may be crucial. Family environment is likely to play an important role; for example, an overweight mother and a single-parent family are associated with an increased likelihood of a child being overweight or obese.

In adolescence, calculation of the body mass index (BMI) does not fully adjust for the effect of height.8, 9 The waist-to-height ratio (WHtR) is regarded as a better marker of adiposity and may be a stronger predictor of cardiovascular disease risk factors. Increasing adiposity in childhood, however, is not necessarily accompanied by a deteriorating metabolic profile. It is likely that a combination of adiposity measures and proinflammatory markers is a better predictor than measurement of adiposity alone. There is an effect of gender on these measures; for example, it is reported that high-sensitivity C-reactive protein (hsCRP) concentrations are higher in girls.

The aim of this study was to examine the effect of gender and puberty on the relationship between measures of adiposity and cardiovascular fitness and (1) inflammatory and metabolic biomarkers known to be associated with disease risk in adults, including serum CRP, insulin, and lipid concentrations and (2) parental BMI and waist circumference. We have previously shown that aerobic fitness, estimated with a 20-m shuttle run test, is inversely related to measures of adiposity in adolescent boys and girls with no significant effect of pubertal status on the relationship. It was hypothesized that, in this group of adolescents, those with greater adiposity and lower cardiovascular fitness are more likely to have a biomarker profile that is associated with increased cardiovascular risk. Furthermore, it was hypothesized that an increased cardiovascular risk profile is more likely in boys and in children whose parents are overweight or obese.

Methods

Participants

In a cross-sectional study of children in year 8 (age range: 12.9–14.4 years) in 3 schools in Carmarthenshire, Wales, information letters were sent to parents and guardians of potential participants. The response rate was 86%. The number of children registered as receiving free school meals was lower than the national average (1% vs. 16%), and was similar in all 3 schools, indicating similar socioeconomic status. Signed consent was obtained from parents or guardians and assent was obtained from children. The study was conducted in accordance with the Declaration of Helsinki and approved by the National Health Service Research Ethics Committee (Dyfed Powys; 07/WMW01/12).

Data on self-assessed pubertal status, along with measurements of weight, waist, height, and skinfold thickness (SKF) were available from 247 participants. The relationship between weight, waist, height, and cardiovascular fitness measurements in that group were presented in a previous publication. For inclusion in the present study, those participants who had a measure of cardiovascular fitness and blood analysis that included insulin concentration were selected for inclusion. A total of 224 participants (129 girls and 95 boys) met the inclusion criteria. Weight, waist, height, and SKF measurements for this group were similar to the larger cohort (data not shown).

Physical measurements

All measurements were carried out by the same researcher, an experienced pediatric exercise physiologist. Children wore light clothing and were barefoot. Privacy was ensured and 2 gender-concordant adults were present at all times. Body height was measured using a portable stadiometer (Holtain Ltd., Crymych, Pembrokeshire, UK) and weight was measured using a calibrated Philips HP 5320 electronic scale (Philips N.V., Amsterdam, the Netherlands). Waist circumference was measured directly over the skin at the smallest circumference between the lower costal margin and iliac crest using anthropometric tape (Holtain Ltd., Crymych, Pembrokeshire, UK). Waist is also reported as a percentage of height (WHtR) when appropriate. SKF measurements were made at the triceps, biceps, subscapular, and suprailiac sites on the right side using Harpenden skin-fold callipers (Holtain Ltd., Brynberian, UK) and standard techniques. Anthropometric measurements were made in duplicate and if the values differed by >1.0 mm or >0.1 kg, a third measurement was taken. The intra-observer technical error of measurement (TEM) was determined in a study of 20 measurements. The TEM was <1.0 mm (coefficient of reliability (R) > 0.99) for height measurement. The TEM for waist was 0.98 mm (R = 0.973), and TEMs for SKF were 0.42 mm (R = 0.996), 0.42 mm (R = 0.989), 0.51 mm (R = 0.993), and 0.54 mm (R = 0.992), respectively, for the triceps, biceps, subscapular, and suprailiac sites. Systolic and diastolic blood pressure was taken 3 times, after the child had been sitting quietly for 5 min (Dinamap IL, Critikron, Inc., Tampa, FL, USA). The average of the second and third readings was recorded.

Parents were asked to complete a form reporting the child's birth weight, as well as their own date of birth and adult height, weight, and waist measurements. Parental self-reported height and weight and/or waist measurements were available from parents of 218 of the 224 children: 217 mothers (mean age = 41.7 years; 95% confidence interval (CI): 41.0–42.3 years) and 207 fathers (mean age = 44.0 years; 95%CI: 43.2–44.9 years). Maternal BMI, calculated from self-reported weight and height, was 26.6 kg/m2 (95%CI: 25.9–27.3 kg/m2; n = 209) and paternal BMI was 28.0 kg/m2 (95%CI: 27.5–28.6 kg/m2; n = 196). Because self-reported height tends to be overestimated and weight underestimated, published equations were used to adjust parental BMI values. The formula used for the mother's value was BMIcorrected = 0.12 + 1.05 × BMIself-reported, and for the father's it was BMIcorrected = 0.12 + 1.05 × BMIself-reported. Corrected maternal BMI was 27.8 kg/m2 (95%CI: 27.1–28.5 kg/m2), and corrected paternal BMI was 29.2 kg/m2 (95%CI: 28.6–29.8 kg/m2).

Pubertal assessment

Pubertal status was determined with self-assessment questionnaires using gender-specific line drawings of the stages based on those described by Tanner. Children completed the questionnaire alone and in private at home. Within each gender group, those reporting being in Tanner stages 1–3 (T1–3) and in Tanner stages 4–5 (T4–5), were combined for data analysis. All children reporting being in Tanner stage 1 (T1) for breast or genital development reported being in Tanner stages 2–4 (T2–4) for pubic hair development (Table 1). Status assessed by breast development or genital development was used for the correlations. Similar patterns were observed in correlations using pubic hair development. Because stages of pubertal development are not equivalent, analyses were performed separately for boys and girls.

Table 1

Stage of puberty in girls and boys: children's estimates of pubertal stages using line drawings described in Methods.

	Girls (breast)						Boys (genitalia)
Pubic hair	1	2	3	4	5	Total	1	2	3	4	5	Total
1	0	0	0	0	0	0	0	0	0	0	0	0
2	1	8	8	1	0	18	1	5	9	2	2	19
3	1	6	29	10	8	54	0	3	12	9	0	24
4	0	3	14	20	9	46	1	1	9	27	7	45
5	0	0	3	5	3	11	0	0	1	3	3	7
Total	2	17	54	36	20	129	2	9	31	41	12	95

Note: Taylor et al., 2001, based on Tanner, 1962.

Cardiovascular fitness

A 20-m shuttle run test was used as an indirect measurement of maximal aerobic power. Participants ran between 2 parallel lines 20 m apart. A commercially available audio tape that emits a beep at the point where the runner should be pivoting at the next line was used. The pacer started at 8.5 km/h and increased by 8.5 km/h each minute and was timed for accuracy before each session. Boys and girls performed separately. Testing took place at the same time of day, supervised by a person trained in the method, who gave consistent verbal encouragement. All participants were fully familiarized with testing procedures before data collection. The test ended if running could not be maintained 2 laps in succession, or voluntarily if the participant was exhausted. The number of laps completed was used as the cardiovascular fitness score.

Biomarkers

Serum was prepared from blood samples collected between 9:00 a.m. and 12:00 noon after an overnight fast and after the child had been sitting for ≥30 min. Glucose was determined by the glucose oxidase method (Randox Laboratories LTD, Crumlin, CO Antrim, UK). Total cholesterol and triglyceride concentrations were determined by routine enzymatic techniques (Vitros 950 System, Ortho-Clinical Diagnostics, Amersham, Bucks, UK). Laboratory analytical variances were 1.5%, 1.6%, and 2.0%, respectively, for these 3 measurements. High-density lipoprotein (HDL) cholesterol was determined after precipitation of very-low-density and LDL with dextran sulphate and magnesium chloride (coefficient of variation (CV): 5.3%). LDL cholesterol concentrations were estimated by the Friedwald formula. Insulin concentration was determined using an enzyme-linked immunosorbent assay (ALPCO Diagnostics, Salem, NH, USA; CV: 7.5%). Interleukin 6 (IL-6) and high-molecular weight adiponectin were measured using enzyme-linked immunosorbent assay kits from R&D Systems (Abingdon, UK; CV of 8.9% and 8.4%, respectively). Concentrations of hsCRP were measured using latex-enhanced immunoturbimetric assay (Randox Laboratories) on a Cobas FARA bioanalyzer (Roche Products Ltd., Herts, UK; lower detection limit, 0.1 mg/L; CV: 5.5%). Fibrinogen was determined using an automated coagulation analyzer (ACL Futura; Instrumentation Laboratory Company, Lexington, MA, USA; CV: 1.6%).

Statistics

Data were tested for normality by examining histograms of values and using the normality plot, Skewness value, and Shapiro-Wilk test. Waist, SKF, and biochemical variables were not normally distributed and were normalized by log-transformation before analysis and are presented as geometric means. The homeostatic model assessment index was calculated using insulin × glucose/22.5.

Sex differences were analyzed by independent (unpaired) Student's t tests. The effects of sex and puberty, or sex and waist measurement, were analyzed by two-way analysis of variance. Log–log regression analysis was used to estimate the power with which to raise the height to correct SKF measurements.8, 22 Pearson correlation coefficients were calculated between pairs of variables. Linear and nonlinear regression analyses were used, as appropriate, to determine the relationship between variables. Hierarchical multiple regression analysis was used to identify independent predictor variables, after ensuring no violation of the assumptions of normality, linearity, multicollinearity, and homoscedasticity. Because patterns differed by gender, genders were also considered separately. Statistical analyses were performed using SPSS Statistics Version 20.0 (IBM Corp., Armonk, NY, USA) and Statistica Version 10.0 (StatSoft Inc., Tulsa, OK, USA). To take into account multiple measurements, the level of statistical significance was determined using the Bonferroni correction. Uncorrected p values are shown. A level of significance of p < 0.05 was set for multiple regression.

Results

Biomarkers associated with metabolic and cardiovascular risk in girls and boys

Biomarkers and cardiovascular fitness measurements were available from 129 girls and 95 boys (Table 2). In this cohort of 13-year-olds, boys had higher cardiovascular fitness scores than girls. They also tended to be taller and have a higher birth weight. Height in girls correlated with birth weight (r = 0.395, p < 0.01; n = 129), but this was not significant in boys (r = 0.146, p = 0.17; n = 92), and there was no relationship between birth weight and any other measurement among girls or boys or among their parents (data not shown). Girls had higher SKF measurements than boys; however, waist circumference expressed as a percentage of height (WHtR) and the ratio of trunk-to-extremity SKF (T/E SKF) did not differ between genders. The small difference in age between T1–3 compared with T4–5 was statistically significant in girls and not in boys (p = 0.016; Table 3).

Table 2

Gender differences in markers of metabolic and cardiovascular risk in adolescent children (mean ± SD) (95%CI).

	Girls	Boys
	(n = 129)	(n = 95)	pa
Age (year)	13.48 ± 0.30 (13.43–13.53)	13.53 ± 0.33 (13.46–13.60)	0.231
Anthropometry
Height (cm)	158.1 ± 6.7 (156.9–159.3)	160.1 ± 9.0 (158.3–161.9)	0.056
Waist (cm)b	65.2 ± 1.1 (63.9–66.6)	67.7 ± 1.1 (66.0–69.5)	0.023
Weight (kg)	53.3 ± 11.0 (51.4–55.2)	53.2 ± 13.1 (50.5–55.8)	0.921
WHtR (%)b	41.3 ± 1.1 (40.5–42.1)	42.4 ± 1.1 (41.4–43.4)	0.088
Birth weight (kg)	3.33 ± 0.36 (3.23–3.43)	3.52 ± 0.59 (3.40–3.64)b	0.017
Subscapular SKF (mm)b	10.8 ± 1.6 (10.0–11.7)	8.8 ± 1.7 (7.9–9.8)	<0.001
Suprailiac SKF (mm)b	12.2 ± 1.6 (11.3–13.3)	9.1 ± 1.9 (8.0–10.4)	<0.001
Triceps SKF (mm)b	16.1 ± 1.4 (15.1–17.2)	12.7 ± 1.6 (11.6–13.9)	<0.001
Biceps SKF (mm)b	10.2 ± 1.5 (9.5–11.0)	7.9 ± 1.6 (7.1–8.7)	0.001
4SKF (mm)b,c	50.2 ± 1.5 (47.1–53.6)	39.2 ± 1.6 (35.4–43.4)	<0.001
T/E SKFb,d	0.87 ± 1.30 (0.84–0.91)	0.87 ± 1.36 (0.82–0.93)	0.915
Blood pressure
Systolic (mmHg)	115.6 ± 10.1 (113.8–117.3)	116.8 ± 12.6 (114.2–119.3)	0.422
Diastolic (mmHg)	65.7 ± 10.2 (63.9–67.5)	64.7 ± 11.0 (62.4–66.9)	0.472
Cardiovascular fitness (laps)	44.5 ± 1.4 (41.9–47.2)	62.6 ± 1.4 (58.4–67.0)	<0.001
Biomarkers
Total cholesterol (mmol/L)b	4.01 ± 1.15 (3.90–4.12)	3.76 ± 1.18 (3.63–3.89)	0.003
LDL cholesterol (mmol/L)b	1.95 ± 1.33 (1.86–2.05)	1.81 ± 1.35 (1.70–1.92)	0.052
HDL cholesterol (mmol/L)b	1.67 ± 1.21 (1.62–1.73)	1.60 ± 1.24 (1.53–1.67)	0.114
Triglycerides (mmol/L)b	0.71 ± 1.43 (0.66–0.75)	0.59 ± 1.53 (0.54–0.64)	<0.001
Glucose (mmol/L)b	4.80 ± 0.27 (4.75–4.85)e	4.92 ± 0.35 (4.85–4.99)f	0.006
Insulin (mIU/L)b	10.02 ± 1.47 (9.37–10.71)	6.96 ± 1.58 (6.34–7.63)	<0.001
HOMA (insulin×glucose/22.5)b	2.16 ± 1.49 (2.01–2.32)e	1.53 ± 1.63 (1.38–1.69)f	<0.001
Fibrinogen (g/L)b	2.62 ± 1.19 (2.54–2.70)g	2.63 ± 1.18 (2.54–2.73)g	0.807
hsCRP (mg/L)b	0.29 ± 2.19 (0.26–0.34)f	0.43 ± 2.38 (0.36–0.52)	<0.001
IL-6 (ng/L)b	0.57 ± 2.09 (0.50–0.64)f	0.69 ± 2.14 (0.59–0.81)g	0.047
HMW Adiponectin (mg/L)b	2.93 ± 1.77 (2.65–3.24)f	2.11 ± 1.89 (1.85–2.40)g	<0.001

Notes: a Unpaired t test girls vs. boys Bonferroni-corrected α = 0.002; b Geometric mean ± SD; c Sum of triceps, subscapular, biceps, and suprailiac SKF; d Ratio of trunk (sum of subscapular and suprailiac)-to-extremity (sum of triceps and biceps) SKF; e Data missing from 3 participants; f Data missing from 2 participants; g Data missing from 1 participant.

Abbreviations: CI = confidence interval; HDL = high-density lipoprotein; HMW = high-molecular weight; HOMA = homeostatic model assessment; hsCRP = high-sensitivity C-reactive protein; IL-6 = interleukin-6; LDL = low-density lipoprotein; SKF = skinfold thickness; T/E SKF = the ratio of trunk-to-extremity skinfold thicknesses; WHtR = waist-to-height ratio.

Table 3

Gradient b (SE) derived from log–log relationships between height and SKF in children who reported being in Tanner stages 1–3 (T1–3) and in Tanner stages 4–5 (T4–5) for breast development in girls and genital development in boys, using line drawings (Taylor et al., 2001) based on Tanner (1962) (mean ± SD).

	Girls		Boys
Pubertal stage	T1–3 (n = 73)	T4–5 (n = 56)	T1–3 (n = 42)	T4–5 (n = 53)
Agea	13.4 ± 0.30 (13.4–13.5)	13.6 ± 0.29 (13.5–13.6) #	13.5 ± 0.36 (13.4–13.6)	13.6 ± 0.30 (13.5–13.7)
4SKFb	2.14 ± 0.93	0.70 ± 1.34	4.66 ± 1.19***	–1.28 ± 0.26
Triceps	1.77 ± 0.92	0.11 ± 1.28	2.73 ± 1.08	–2.23 ± 1.19
Biceps	0.49 ± 0.99	0.51 ± 1.59	3.53 ± 1.14**	–2.26 ± 1.36
Subscapular	2.84 ± 1.08*	0.27 ± 1.67	6.05 ± 1.27***	0.18 ± 1.21
Suprailiac	3.51 ± 1.15**	2.11 ± 1.61	6.66 ± 1.59***	–0.43 ± 1.66
T/E SKFc	1.91 ± 0.58**	1.10 ± 0.93	3.37 ± 0.64***	2.08 ± 0.75**

Notes: a Data presented as mean ± SD (95%CI); b Sum of triceps, subscapular, biceps, and suprailiac SKF; c Trunk-to-extremity SKF ratio ((subscapular+suprailiac)/(triceps+biceps)); Bonferroni-corrected α = 0.01.

* p ≤ 0.01, ** p ≤ 0.005, *** p ≤ 0.001, significant relationship between height and SKF; #p = 0.016, compared with girls in T1–3 (independent t test).

Abbreviations: CI = confidence interval; SKF = skinfold thickness; T/E SKF = the ratio of trunk-to-extremity skinfold thicknesses SKF.

There was a relationship between height and the sum of the SKFs (4SKF) in children in T1–3 (r = 0.279, p = 0.017, n = 73 for girls; and r = 0.563, p < 0.001, n = 42 for boys), but not in T4–5 (r = 0.078, p = 0.570, n = 56 for girls; and r = –0.156, p = 0.265, n = 53 for boys). Because 4SKF is dependent on height, the relationship between height and each SKF was also determined. Gradients obtained from log–log linear regression analysis of height and SKF (Table 3) indicate that most of the effect of puberty on the relationship between height and 4SKF was from the contribution of subscapular SKF and suprailiac SKF measurements. This finding was markedly apparent in T1–3 boys. There was no significant relationship between triceps SKF and height in any group. There was a positive relationship between T/E SKF and height in girls in T1–3 and in boys in T1–3 and T4–5.

There was a similar relationship between WHtR and triceps SKF or T/E SKF irrespective of gender or pubertal status (Fig. 1). Nonlinear regression lines and correlations did not differ significantly in slope; however, in boys with a triceps SKF of ≥10 mm, the mean deviation of the WHtR was 7.5% (6.3%–8.6%) above the girls’ curvilinear regression line (p < 0.001). The regression lines in girls and boys crossed a WHtR of 44% at triceps SKF measurements of 23 mm and 16.5 mm, respectively (i.e., values were 42% higher in girls), whereas the regression lines crossed a WHtR of 44% at similar T/E SKF measurements in girls and boys.

Fig. 1

Relationship between waist-to-height ratio (WHtR) and triceps skinfold thickness (SKF) or the ratio of trunk-to-extremity SKF (T/E SKF), in girls (A, C) and boys (B, D). The open symbols represent those self-reporting being in Tanner stages 1–3 for breast development in girls and genital development in boys. The closed symbols represent Tanner stages 4–5. Nonlinear regression lines and correlations for the relationships are indicated by the solid lines. (A) lnWHtR = 4.264 – 0.601 × lnTricepsSKF + 0.144 × lnTricepsSKF, r2 = 0.538, p < 0.001 (129 girls); (B) lnWHtR = 3.842 – 0.287 × lnTricepsSKF + 0.095 × lnTricepsSKF, r2 = 0.690, p < 0.001 (95 boys); (C) lnWHtR = 3.738 + 0.294 × lnT/E SKF + 0.298 × lnT/ESKF2, r2 = 0.308, p < 0.001 (129 girls); (D) lnWHtR = 3.746 + 0.247 × lnT/ESKF + 0.308 × lnT/ESKF2, r2 = 0.271, p < 0.001 (95 boys). SKF = skinfold thickness; T/E SKF = the ratio of trunk-to-extremity skinfold thicknesses; WHtR = waist-to-height ratio.

Serum insulin concentrations were higher in girls than in boys (Table 2) and correlated positively with WHtR in girls and boys (Fig. 2), regardless of pubertal status (data not shown). Glucose levels were lower in girls than in boys, and correlated positively with insulin (r = 0.235, p = 0.008, n = 126 for girls; and r = 0.398, p < 0.001, n = 93 for boys). In boys, insulin concentrations correlated with height z scores (r = 0.451, p < 0.001, n = 95 for boys; and r = 0.119, p = 0.181, n = 129 for girls). In hierarchical multiple regression analysis, glucose and WHtR were entered at Step 1 and explained 11% of the variance in insulin. After entry of gender and cardiovascular fitness at Step 2, the total variance in insulin explained by the model was 34%, F(4, 214) = 27.70, p < 0.001. Gender and cardiovascular fitness explained an additional 23% of the variance in insulin after controlling for glucose and WHtR, F(2, 214) = 38.15, p < 0.001. In the final model, the following were statistically significant: glucose (β = 0.29, p < 0.001), WHtR (β = 0.26, p < 0.001), and gender (β = 0.45, p < 0.001).

Fig. 2

Relationship between waist-to-height ratio (WHtR, %) and other markers of metabolic and cardiovascular risk in adolescent girls (closed symbols, intact line) and boys (open symbols, broken line). Linear regression lines and correlations for the relationships are as follows. (A) lnInsulin = 1.041 × lnWHtR – 1.568; r = 0.288, p < 0.001 (129 girls) and lnInsulin = 1.572 × lnWHtR–3.949; r = 0.394, p < 0.001 (95 boys); (B) lnFibrinogen = 0.948 × lnWHtR–2.565; r = 0.585, p < 0.001 (128 girls) and lnFibrinogen = 0.702 × lnWHtR – 1.662; r = 0.477, p < 0.001 (94 boys); (C) lnTriglyceride = 0.771 × lnWHtR–3.219; r = 0.226, p = 0.010 (129 girls) and lnTriglyceride = 1.186 × lnWHtR–4.977; r = 0.322, p = 0.002 (95 boys); (D) lnHDL = 3.309–0.751 × lnWHtR; r = –0.411, p < 0.001 (129 girls) and lnHDL = 2.407–0.517 × lnWHtR; r = –30.273, p = 0.008 (95 boys); (E) lnCRP = 4.14 × lnWHtR–16.62; r = 0.553, p < 0.001 (127 girls) and lnCRP = 3.46 × lnWHtR–13.80; r = 0.456, p < 0.001 (95 boys); (F) DBP=24.29 × lnWHtR–24.66; r = 0.252, p = 0.004 (129 girls) and DBP = 31.80 × lnWHtR–54.46; r = 0.330, p < 0.001 (95 boys). DBP = diastolic blood pressure; HDL = high-density lipoprotein; hsCRP = high-sensitivity C-reactive protein.

Serum concentrations of triglycerides and total cholesterol were higher in girls (Table 2), regardless of pubertal status (data not shown). Fibrinogen and triglyceride concentrations, and diastolic blood pressure levels, each correlated positively with WHtR in boys and girls, while HDL cholesterol was inversely correlated (Fig. 2).

HMW adiponectin concentrations were lower in boys (Table 2) and were lower in late puberty, analysis of variance (ANOVA) F(3, 217) = 8.201; gender p < 0.001 and puberty p = 0.012; interaction p = 0.138. Concentrations of HMW adiponectin were 2.52 mg/L (95%CI: 2.09–3.04 mg/L) in the 42 T1–3 boys and 1.82 mg/L (95%CI: 1.53–2.17 mg/L) in the 52 T4–5 boys. In girls, values were 2.80 mg/L (95%CI: 2.36–3.31 mg/L) in the 71 T1–3 girls and 3.04 mg/L (95%CI: 2.69–3.45 mg/L) in the 56 T4–5 girls. In hierarchical multiple regression analysis, gender and puberty were entered at Step 1 and explained 9% of the variance in HMW adiponectin. After entry of WHtR, insulin and triceps SKF at Step 2, the total variance in HMW adiponectin explained by the model was just 15%, F(5, 215) = 7.65, p < 0.001. WHtR, insulin and T/E SKF explained an additional 6% of the variance in HMW adiponectin after controlling for gender and puberty, F(3, 215) = 4.94, p = 0.002. In the final model, the following were statistically significant: gender (β = 0.30, p < 0.001), puberty (β = 0.14, p = 0.032), and T/E SKF (β = –0.15, p = 0.035).

hsCRP concentrations were significantly lower in the girls compared with the boys (Table 2) and correlated with IL-6 (r = 0.360, p < 0.001 in 125 girls; and r = 0.466, p < 0.001 in 94 boys). There was an association between CRP and WHtR in girls and boys (Fig. 2). In hierarchical multiple regression analysis, gender, IL-6, and WHtR were entered at Step 1 and explained 37% of the variance in CRP. After entry of puberty, insulin, T/E SKF, and cardiovascular fitness at Step 2, the total variance in CRP explained by the model was 36%, F(4, 211) = 18.58, p < 0.001. In the final model the following were statistically significant: WHtR (β = 0.39, p < 0.001), IL-6 (β = 0.29, p < 0.001), and gender (β = 0.14, p = 0.045).

Characteristics of adolescents with higher WHtR

We compared children with the highest waist circumferences (>44% of height; 35 girls and 26 boys) with the rest of the cohort (94 girls and 69 boys; Table 4). There were no differences in pubertal status among the 4 groups (data not shown). The T/E SKF was higher in the group with a WHtR of >44% in both girls and boys. Most children with a WHtR of >44% had a triceps SKF measurement of >23 mm in girls and >16.5 mm in boys (Fig. 1A and 1B). These children also had higher diastolic blood pressure, insulin concentrations, and homeostatic model assessment measurements, and CRP and fibrinogen concentrations, and lower HDL cholesterol concentrations, than the rest of the cohort. The cardiovascular fitness score was lower in girls and boys with the higher WHtR. In boys with a WHtR of >44%, there was an inverse correlation with insulin concentrations (lnInsulin = 6.251 – 1.050 × lnFitnessScore; r = –0.727, p < 0.001), which was not seen in thinner boys or in girls (data not shown).

Table 4

Characteristics of children with waist measurements that were >44% or ≤44% height (mean (95%CI)).

WHtR (%)	>44%		≤44%		pa
	Girls	Boys	Girls	Boys	Waist	Sex	Interaction
Gender group (n (%))	35 (27%)	26 (27%)	94 (73%)	69 (73%)
Anthropometry
Height (cm)	159.3 (157.1–161.5)	160.4 (156.3–164.5)	157.7 (156.3–159.1)	160.0 (157.9–162.1)	0.393	0.145	0.598
WHtR (%)b	47.8 (46.8–49.0)	49.4 (47.9–50.9)	39.1 (38.7–39.5)	40.0 (39.4–40.6)	<0.001	0.003	0.584
4SKF (mm)b,c	78.5 (72.7–84.7)	71.4 (60.2–84.7)	42.6 (40.3–45.0)	31.3 (29.1–33.6)	<0.001	<0.001	0.017
T/E SKFb,d	1.06 (0.98–1.15)	1.02 (0.90–1.17)	0.81 (0.77–0.85)	0.82 (0.76–0.87)	<0.001	0.741	0.644
Triceps SKF (mm)b	23.3 (21.1–25.7)	20.7 (19.0–23.7)	14.0 (13.3–14.9)	10.6 (9.7–11.4)	<0.001	<0.001	0.078
Weight (kg)	66.4 (63.2–69.5)	65.7 (59.3–72.2)	48.5 (47.1–49.8)	48.4 (46.5–50.3)	<0.001	0.803	0.824
Birth weight (kg)	3.37 (3.14–3.60)	3.46 (3.19–3.73)e	3.31 (3.20–3.43)	3.54 (3.40–3.68)e	0.613	0.044	0.976
Blood pressure
Systolic (mmHg)	117.3 (114.7–120.0)	117.5 (111.2–123.9)	114.9 (112.7–117.1)	116.5 (113.8–119.2)	0.307	0.599	0.681
Diastolic (mmHg)	70.5 (67.4–73.6)	68.3 (63.0–73.7)	63.9 (61.9–66.0)	63.3 (61.0–65.6)	<0.001	0.375	0.629
Cardiovascular fitness (laps)	35.3 (31.3–39.2)	52.8 (44.6–61.0)	51.4 (48.4–54.5)	70.7 (66.5–74.9)	<0.001	<0.001	0.711
Biomarkers
Total cholesterol (mmol/L)b	3.97 (3.75–4.21)	3.69 (3.43–3.98)	4.02 (3.90–4.15)	3.78 (3.64–3.93)	0.468	0.006	0.809
LDL cholesterol (mmol/L)b	2.05 (1.86–2.27)	1.81 (1.58–2.06)	1.92 (1.81–2.03)	1.81 (1.68–1.94)	0.449	0.039	0.454
HDL cholesterol (mmol/L)b	1.52 (1.43–1.62)	1.49 (1.37–1.62)	1.73 (1.67–1.80)	1.64 (1.56–1.73)	<0.001	0.223	0.627
Triglycerides (mmol/L)b	0.76 (0.66–0.87)	0.67 (0.56–0.81)	0.69 (0.64–0.73)	0.56 (0.50–0.61)	0.012	0.005	0.410
Glucose (mmol/L)b,f	4.81 (4.72–4.90)	4.89 (4.76–5.01)	4.80 (4.74–4.85)	4.93 (4.84–5.01)	0.783	0.027	0.569
Insulin (mIU/L)b	11.4 (10.1–12.9)	8.7 (7.0–10.7)	9.5 (8.8–10.3)	6.4 (5.8–7.1)	<0.001	<0.001	0.314
HOMA (insulin×glucose/22.5) b,f	2.50 (2.20–2.84)	1.93 (1.53–2.42)	1.97 (1.78–2.20)	1.37 (1.21–1.55)	<0.001	<0.001	0.482
Fibrinogen (g/L)b,g	3.04 (2.86–3.23)	2.96 (2.82–3.12)	2.48 (2.41–2.55)	2.52 (2.42-2.62)	<0.001	0.848	0.355
hsCRP (mg/L)b	0.62 (0.45–0.85)	0.74 (0.54–1.03)	0.23 (0.20–0.25)	0.35 (0.29–0.43)	<0.001	0.005	0.240
IL-6 (ng/L)b,h	0.78 (0.63–0.95)	0.76 (0.55–1.04)	0.50 (0.43–0.59)	0.67 (0.56–0.81)	0.016	0.241	0.157
HMW adiponectin (mg/L)b,h	2.75 (2.25–3.37)	1.88 (1.41–2.51)	3.00 (2.67–3.38)	2.19 (1.89–2.54)	0.188	<0.001	0.707
Parental data (mean (95%CI; n))
Maternal BMI (kg/m2)	28.8 (26.7–30.9; 33)	28.3 (26.5–30.0; 26)	25.6 (24.6–26.5; 85)	26.1 (25.1–27.2; 65)	0.001	0.677	0.231
Maternal waist2/htx10b	4.37 (3.91–4.89; 29)	4.31 (3.82–4.85; 24)	3.78 (3.55–4.03; 79)	3.75 (3.51–4.01; 63)	0.001	0.774	0.838
Paternal BMI (kg/m2)	28.6 (26.9–30.3; 28)	30.6 (28.7–32.5; 22)	27.4 (26.5–28.2; 81)	27.8 (26.7–28.7; 66)	0.004	0.094	0.225
Paternal waist2/htx10b	4.61 (4.34–4.90; 27)	5.02 (4.59–5.49; 21)	4.48 (4.33–4.65; 78)	4.63 (4.45–4.82; 66)	0.070	0.033	0.293

Notes: a Two-way analysis of variance, Bonferroni-corrected α = 0.002; b Geometric mean; c Sum of triceps, subscapular, biceps and suprailiac SKF; d Ratio of trunk (sum of subscapular and suprailiac)-to-extremity (sum of triceps and biceps) SKF; e Data missing for 1 individual; f Data missing for 3 girls ≤ 44% and 2 boys ≤ 44%; g Data for 1 girl ≤ 44% and 1 boy ≤ 44%; h Data missing for 1 boy > 44%, 2 girls ≤ 44%.

Abbreviations: BMI = body mass index; CI = confidence interval; HMW = high-molecular weight; HDL = high-density lipoprotein; HOMA = homeostatic model assessment; hsCRP = high-sensitivity C-reactive protein; IL-6 = interleukin 6; LDL = low-density lipoprotein; SKF = skinfold thickness; T/E SKF = trunk-to-extremity SKF; WtHR = waist-to-height ratio.

Parental weight and waist measurements

Parental weight measurements correlated with height (mothers: r = 0.315, p < 0.001; fathers: r = 0.381, p < 0.001) and correction of weight by height2 (BMI) removed the effect of height. In men, the waist and WHtR correlated with height (r = 0.177, p = 0.014). When the formula waist2× 10/ht was used, there was no relationship between waist and height in mothers or fathers. According to World Health Organization criteria, and using corrected BMI values, 33% of mothers were normal weight and 29% were obese (BMI ≥ 30), and 11% of fathers were normal weight and 35% were obese.

Relationship between child and parental anthropometric variables

In the children with a WHtR of >44%, maternal BMI and waist2 × 10/ht were higher than for mothers of children with a WHtR of ≤44% (Table 4). Paternal BMI was also significantly higher. Values from children for whom both maternal and paternal BMI were available were included in the following analyses (93 girls and 80 boys).

Correlations between anthropometric variables in children and their parents are shown in Table 5. In girls, WHtR correlated significantly with maternal BMI. There was no correlation between maternal and paternal BMI; however, there was a significant relationship between maternal and paternal waist2 × 10/ht (data not shown).

Table 5

Correlations between anthropometric variables in parents and children (Pearson's r).

	Girls (n = 93)					Boys (n = 80)
	Height	BMI	WHtRa	T/E SKFa	Triceps SKFa	Height	BMI	WHtRa	T/E SKFa	Triceps SKFa
Child BMI	0.196	—	—	—	—	0.304***	—	—	—	—
Child WHtRa	–0.023	0.897***	—	—	—	–0.002	0.881***	—	—	—
Child T/E SKFa	0.268***	0.509***	0.497***	—	—	0.454***	0.573***	0.433***	—	—
Child Triceps SKFa	0.133	0.748***	0.700***	0.125	—	0.019	0.764***	0.797***	0.076	—
Maternal height	0.359***	–0.029	–0.050	0.151	–0.075	0.337***	0.132	0.056	–0.079	0.209
Paternal height	0.297***	0.004	–0.042	–0.063	0.111	0.145	0.068	0.034	0.012	0.182
Midparental heightb	0.423***	–0.014	–0.060	0.044	0.035	0.324***	0.134	0.060	–0.047	0.259*
Maternal BMI	0.094	0.351***	0.324***	0.172	0.350***	0.181	0.286***	0.225*	0.129	0.279*
Paternal BMI	–0.160	0.215*	0.204*	0.291***	0.011	0.066	0.315***	0.263*	0.254*	0.133
Maternal W2HtRa	0.123	0.189	0.199	0.201	0.211*	0.271*	0.307***	0.261*	0.236*	0.301***
Paternal W2HtRa	–0.087	0.068	0.108	0.198	–0.065	0.070	0.210	0.198	0.192	0.120

Notes: a Log-transformed; b For girls = (father's height – 13 cm + mother's height)/2; For boys = (mother's height + 13 cm + father's height)/2. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001; Bonferroni-corrected α = 0.004.

Abbreviations: BMI = body mass index; SKF = skinfold thickness; T/E SKF = trunk-to-extremity SKF; W2HtR = waist × 10/ht; WHtR = waist-to-height ratio.

Hierarchical multiple regression analysis was used to determine the impact of parental BMI on children's WHtR, triceps SKF, and T/E SKF. Gender and cardiovascular fitness were entered at Step 1 and explained 25% of the variance in child WHtR. After entry of maternal and paternal BMI at Step 2, the total variance in child WHtR explained by the model was 33%, F(4, 184) = 22.22, p < 0.001. Maternal and paternal BMI explained an additional 8% of the variance in child WHtR after controlling for gender and cardiovascular fitness, F(2, 184) = 10.73, p < 0.001. In the final model, the following independent variables were statistically significant: gender (β = 0.31, p < 0.001), cardiovascular fitness (β = –0.49, p < 0.001), maternal BMI (β = 0.22, p < 0.001), and paternal BMI (β = 0.17, p = 0.007). For child triceps SKF, gender and cardiovascular fitness, entered at Step 1, explained 32.5% of the variance. After entry of maternal and paternal BMI at Step 2, the total variance in child triceps SKF explained by the model was 37.3%, F(4, 184) = 27.38, p < 0.001. Maternal and paternal BMI explained an additional 4.8% of the variance, F(2, 184) = 7.09, p < 0.001. In the final model, the following were statistically significant: cardiovascular fitness (β = –0.52, p < 0.001) and maternal BMI (β = 0.22, p < 0.001). For child T/E SKF, gender and cardiovascular fitness, entered at Step 1, explained 7% of the variance. After entry of maternal and paternal BMI at Step 2, total variance in child triceps SKF explained by the model was 14%, F(4, 184) = 7.47, p < 0.001. Maternal and paternal BMI explained an additional 7% of the variance, F(2, 184) = 7.38, p = 0.001. In the final model, the following were statistically significant: cardiovascular fitness (β = –0.25, p = 0.001) and paternal BMI (β = 0.22, p = 0.002).

We have previously shown that the cardiovascular fitness score is inversely related to WHtR and to 4SKF in girls and boys in early/mid and late puberty. Because 4SKF depends on height, we explored the relationship between cardiovascular fitness and triceps SKF. There is an inverse relationship, with no difference between those in T1–3 and T4–5 for each gender, and with similar combined slopes for girls (fitness score = 107.7–21.82 × lnTricepsSKF, r = 0.497, p < 0.001, n = 129) and boys (lnWHtR = 3.842–0.287 × lnTricepsSKF  + 0.095 × lnTricepsSKF, r = 0.752, p < 0.001, n = 95). However, the combined regression line was significantly higher for boys compared with girls, F(1, 221) = 39.477, p < 0.01. In a hierarchical multiple regression analysis, gender and WHtR were entered at Step 1 and explained 39% of the variance in cardiovascular fitness. After entry of maternal and paternal BMI at Step 2, the total variance in cardiovascular fitness explained by the model was 39%, F(4, 184) = 29.58, p < 0.001. In the final model, the following were statistically significant: gender (β = 0.50, p < 0.001) and WHtR (β = –0.45, p < 0.001), with no independent contribution of maternal BMI or paternal BMI.

Discussion

In this study of adolescents, measures of adiposity correlated with biomarkers that are associated with cardiovascular disease risk in adults. Waist and SKF measurements correlate with height in children in early or mid-puberty; however, the influence of height is lost when waist measurement is expressed as a percentage of height (WHtR). Gender differences were observed. Although girls seemed to have more subcutaneous fat and decreased levels of cardiovascular fitness, boys had relatively greater central adiposity and higher levels of proinflammatory markers. Parental overweight and obesity were associated with greater adiposity in adolescent girls and boys, suggesting that strategies for decreasing cardiovascular risk should be family focused.

The cohort was well-controlled for age and socioeconomic status, and we were therefore able to estimate the independent effects of puberty and parental adiposity. There were, however, limitations. This was a cross-sectional design, and a comparison of children in T1–3 and T4–5 in longitudinal studies would be required to predict the effect of puberty in individual subjects. Furthermore, pubertal status and parental anthropometry (height, weight, and waist measurements) were self-reported by participants. Self-reported height tends to be overestimated and weight underestimated, leading to an underestimation of obesity prevalence and an exaggeration of the relationship with cardiovascular disease risk. We used the protocol developed by Taylor et al. to estimate pubertal development. It should also be noted that children tend to underestimate pubertal development when using these line drawings.

Sex hormones influence adipocyte deposition and function, and adolescence has been considered a critical time in the development of obesity.27, 28 However, although there is a relationship between obesity and the early onset of puberty in girls, the data for boys are inconclusive. There is also insufficient evidence that puberty is causally linked to obesity development. In a large cross-sectional study, sexual dimorphism in fat patterning was present before puberty and increased across puberty, with girls having less waist fat. The trend in British adolescents over recent decades for having increases in waist circumference exceed increases in BMI, particularly in girls, suggests that abdominal fatness is increasing at a greater rate than whole body fatness. In our study, despite having triceps SKF that was lower, boys had similar WHtR compared with girls. This observation could be explained by a relatively greater contribution of visceral fat to the abdominal measurement in boys. Assessing the value of using WHtR and SKF measurements (triceps and T/E ratios) to track adiposity across puberty would require longitudinal studies with larger cohorts.

We identified gender differences in circulating concentrations of biomarkers that are associated with cardiovascular disease. Fasting insulin and triglyceride concentrations were higher in girls than in boys. In boys with a higher WHtR, there was an inverse relationship between cardiovascular fitness and insulin levels. It is now recognized that cardiorespiratory fitness influences the relationship between adiposity and cardiovascular prognosis.4, 32 In boys, fat mass accrual during emerging adulthood is mitigated by physical activity. It, therefore, could be speculated that encouraging physical fitness in this group might have a significant impact in decreasing cardiometabolic risk. Higher hsCRP levels were observed in boys, which is consistent with a previous study of obese adolescents. In contrast, in prepubertal children, CRP is reported to be higher in girls and adult women independent of exogenous estrogen. In adults, there is a strong inverse relationship between hsCRP levels and adiposity, and these relationships independently predict cardiovascular disease events. Although CRP levels in children predict values in adults and predict adult obesity, evidence that CRP in children is a predictor of cardiovascular risk in adulthood is not strong. In obese girls, high hsCRP concentrations are associated with insulin resistance. In our study, although hsCRP correlated with WHtR in boys and girls, there was no relationship to fasting insulin. In a linear regression analysis, there was an influence of WHtR on hsCRP concentrations that is independent of the ratio of T/E SKF. HMW adiponectin, which has both anti-inflammatory and insulin-sensitizing properties, is reported to be inversely related to adiposity and insulin resistance. These relationships were not present in our study. However, we did observe that concentrations were lower in boys, particularly in the late puberty group, which may be explained by a direct effect of testosterone on adipocyte production. Lower adiponectin concentrations, taken together with relatively greater waist circumference measurements and higher CRP levels, suggest that adolescent boys have more visceral adiposity and associated systemic inflammation.

It has been suggested that a WHtR of >0.5 in children should be used to predict health risk when those children become adults. A study of Australian children aged 8–16 years showed that a WHtR of ≥0.46 for boys and ≥0.45 for girls identified those with percentage body fat in the ≥85th percentile. In black South African adolescents, a lower WHtR cutoff of 0.41 indicated metabolic risk. In our study, adolescents with a WHtR of >0.44 had higher levels of cardiovascular biomarkers. It has been suggested that WHtR further specifies cardiometabolic risk within classifications that are based on BMI percentiles. We observed that parental BMI measurements were also higher in those with a WHtR of >0.44. Although this finding may indicate that childhood overweight and obesity are strongly related to the social environment, genetic factors may also play a role. Birth weight is reported to predict later obesity. In our study, the child's birth weight reported by the parents was associated with height in girls; however, an association with markers of adiposity was not observed, suggesting that birth weight may not be a consistent predictor of later overweight and obesity.

In our group of 12-year-olds, pubertal status had no impact on the level of physical fitness in girls or boys. In a recent longitudinal study of younger children, persistently low, or a decrease in, cardiorespiratory fitness was associated with later cardiovascular disease risk. Although cardiovascular fitness was not related to parental BMI in our study, the observation that parental overweight and obesity is associated with higher waist measurements in children suggests that strategies for reducing cardiovascular risk should be family focused.

Conclusion

In adolescents, there is a relationship between measures of adiposity and parental weight that involves factors other than cardiovascular fitness. Adolescent boys have relatively more abdominal fat than girls and tend to have a proinflammatory profile of biomarkers. These observations suggest that family and social environmental interventions to prevent obesity are best undertaken early in childhood, particularly in boys.